(Q47812425)

5 February 2018

title

Immunogenicity, safety, and protective efficacy of an inactivated SARS-associated coronavirus vaccine in rhesus monkeys (English)

1 reference

5 February 2018

0 references

1 reference

1 reference

Jun Zhou

1

1 reference

5 February 2018

Wei Wang

2

1 reference

5 February 2018

Qiong Zhong

3

1 reference

5 February 2018

Wei Hou

4

1 reference

5 February 2018

Zhanqiu Yang

5

1 reference

5 February 2018

Shu-Yuan Xiao

6

1 reference

5 February 2018

Runqing Zhu

7

1 reference

5 February 2018

Zhijiao Tang

8

1 reference

5 February 2018

Yong Wang

9

1 reference

5 February 2018

Qiaoyang Xian

10

1 reference

5 February 2018

Hongbing Tang

11

1 reference

5 February 2018

Li Wen

12

1 reference

5 February 2018

language of work or name

English

0 references

publication date

1 May 2005

1 reference

5 February 2018

published in

Vaccine

1 reference

5 February 2018

volume

23

1 reference

5 February 2018

issue

24

1 reference

5 February 2018

page(s)

3202-3209

1 reference

5 February 2018

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.075

SARS coronavirus: a new challenge for prevention and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.075

A novel coronavirus associated with severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.075

Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.075

Coronavirus as a possible cause of severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.075

Custom-made vaccines at speed.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.075

Serologic and molecular biologic methods for SARS-associated coronavirus infection, Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.075

The clinical pathology of severe acute respiratory syndrome (SARS): a report from China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.075

Aetiology: Koch's postulates fulfilled for SARS virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.075

Effects of a SARS-associated coronavirus vaccine in monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.075

Intranasal immunization with inactivated SARS-CoV (SARS-associated coronavirus) induced local and serum antibodies in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.075

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.075

Antibody-dependent enhancement of feline infectious peritonitis virus infection in feline alveolar macrophages and human monocyte cell line U937 by serum of cats experimentally or naturally infected with feline coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.075

Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.075

7 January 2021

inferred from DOI database lookup

Monoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody-dependent enhancement of infection of feline macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.075

7 January 2021

inferred from DOI database lookup

Polio and rabies vaccines produced in continuous cell lines: a reality for Vero cell line

1 reference

12 December 2020

The large-scale cultivation of VERO cells in micro-carrier culture for virus vaccine production. Preliminary results for killed poliovirus vaccine

1 reference

12 December 2020

Dynamic changes in blood cytokine levels as clinical indicators in severe acute respiratory syndrome

1 reference

12 December 2020

The biological characteristics of SARS virus and its related coronaviruses

1 reference

12 December 2020

10.1016/J.VACCINE.2004.11.075

Identifiers

DOI

1 reference

5 February 2018

1 reference

5 February 2018